The effect of federal and state off-label marketing investigations on drug prescribing: The case of olanzapine

In the past decade, the federal government has frequently investigated and prosecuted pharmaceutical manufacturers for illegal promotion of drugs for indications not approved by the Food and Drug Administration (FDA) (“off-label” uses). State governments can choose to coordinate with the federal inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bo, Studdert, David M., Sarpatwari, Ameet, Franklin, Jessica M., Landon, Joan, Kesselheim, Aaron S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384770/
https://www.ncbi.nlm.nih.gov/pubmed/28388667
http://dx.doi.org/10.1371/journal.pone.0175313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384770/
https://www.ncbi.nlm.nih.gov/pubmed/28388667
http://dx.doi.org/10.1371/journal.pone.0175313

Ejemplares similares